| Project/Area Number |
12670104
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
General medical chemistry
|
|---|
| Research Institution | Tohoku University |
|---|
Principal Investigator |
KOBAYASHI Akira Tohoku university school of medicine, Research Associate, 大学院・医学系研究科, 助手 (50292214)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
古山 和道 東北大学, 大学院・医学系研究科, 助手 (80280874)
|
|---|
| Project Period (FY) |
2000 – 2001
|
| Project Status |
Completed (Fiscal Year 2001)
|
| Budget Amount *help |
¥3,400,000 (Direct Cost: ¥3,400,000)
Fiscal Year 2001: ¥1,200,000 (Direct Cost: ¥1,200,000)
Fiscal Year 2000: ¥2,200,000 (Direct Cost: ¥2,200,000)
|
|---|
| Keywords | Transcriptional regulation / transcription factor / cancer development / apoptosis / T cell |
|---|
| Research Abstract |
Transcription factor Nrf3 is supposed to play roles in colon cancer and T cell development. Previous results tell us that Nrf3 is digested with Caspase9, resulting in cell death. So I examined function of Nrf3 in colon cancer, T cell development and apoptosis.
1) For examination of physiological roles of Nrf3, I generated a Nrf3 gene targeting mouse (knock out mouse) and a T cell-specific overexpression transgenic mouse.
2) Nrf3 knockout mouse is viable and fertile. Phenotype are observed in T cell and a certain sensorium.
3) Nrf3 overexpression transgenic mice were lethal. This data shows us that overexpression of Nrf3 is toxic to cells.
|
